Skip to content
Clinical Trials – home
AustriaBack to Austria

Clinical trials in Braunau Am Inn – page 3

77 clinical trials in Braunau Am Inn, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Braunau Am Inn at a glance
77
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

77 trials in Braunau Am Inn

Open in trial search

Study on TAK-330 for Reversing Anticoagulation in Patients on Factor Xa Inhibitors Needing Urgent Surgery

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Protein C
  • Sponsor:Takeda Development Center Americas Inc.

Breast cancer

Recruiting

Study on the Effectiveness of Inavolisib with Trastuzumab and Pertuzumab for Patients with HER2-Positive, HR-Positive, PIK3CA Mutant Early Breast Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Inavolisib
  • Sponsor:GBG Forschungs GmbH

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Arteriosclerosis

Not yet recruiting

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Muvalaplin
  • Sponsor:Eli Lilly & Co.

Arteriosclerosis

Not yet recruiting

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Olpasiran
  • Sponsor:Amgen Inc.

Fibromyalgia

Not yet recruiting

Efficacy and Safety of ADEZUNAP (AP707) in Adults with Fibromyalgia Syndrome – Phase II Placebo‑Controlled Washout Study

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Adezunap
  • Sponsor:Apurano Pharmaceuticals GmbH

Pulmonary hypertension

Not yet recruiting

A study to evaluate the effectiveness of levosimendan in patients with pulmonary hypertension and heart failure with preserved ejection fraction.

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Levosimendan
  • Sponsor:Tenax Therapeutics Inc.

Pharyngitis

Not yet recruiting

Study of benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for treating acute pharyngitis symptoms

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:2,4 dichlorobenzyl alcohol
  • Sponsor:MEDICE Arzneimittel Puetter GmbH & Co. KG

Hypertrophic cardiomyopathy

Not yet recruiting

Study on Mavacamten for Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Mavacamten
  • Sponsor:Myokardia Inc.

Acne

Not yet recruiting

Study on the Effectiveness and Safety of Clindamycin and Tretinoin Gel for Patients with Papulopustular Acne

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Clindamycin
  • Sponsor:Dermapharm AG

Cardiac failure

Not recruiting

A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Study on the Immune Response and Safety of RSVPreF3 OA Vaccine in Adults Aged 60+ with Respiratory Syncytial Virus Infections

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:GSKVx000000017064
  • Sponsor:GlaxoSmithKline Biologicals

Other cities in Austria

The busiest research cities in the country

All 48 cities in Austria

Clinical research in Braunau Am Inn

What the registry says about research in the country

01 Cardiovascular Disease Prevention

Innovative research focusing on stroke prevention and managing atrial fibrillation, with trials evaluating new anticoagulant therapies and comparing their effectiveness to existing treatments.

  • Stroke Prevention Studies
  • Atherosclerotic Disease Management
  • Blood Clot Prevention

Studies are investigating novel approaches to reduce cardiovascular events in high-risk patients.

02 Heart Failure Research

Comprehensive studies examining treatments for chronic heart failure, particularly in patients with reduced ejection fraction and kidney function impairment.

  • Combination Therapy Evaluation
  • Cardiac Function Improvement
  • Quality of Life Assessment

Research aims to enhance treatment outcomes and reduce hospitalization rates.

03 Cardiomyopathy Studies

Advanced research into both obstructive and non-obstructive hypertrophic cardiomyopathy, evaluating innovative treatments to improve patient symptoms and physical capabilities.

  • Cardiac Structure Analysis
  • Exercise Capacity Improvement
  • Symptom Management

Trials focus on structural heart changes and functional improvements.

04 Metabolic Disease Management

Investigating treatments for patients with type 2 diabetes and obesity, focusing on cardiovascular risk reduction and improved metabolic outcomes.

  • Diabetes Treatment Optimization
  • Weight Management
  • Cardiovascular Risk Reduction

Studies aim to develop comprehensive treatment approaches for complex metabolic conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.